data_QOP # _chem_comp.id QOP _chem_comp.name 6-amino-5-chloro-N-[(1R)-1-(5-{[5-chloro-4-(trifluoromethyl)pyridin-2-yl]carbamoyl}-1,3-thiazol-2-yl)ethyl]pyrimidine-4-carboxamide _chem_comp.type non-polymer _chem_comp.pdbx_type HETAIN _chem_comp.formula "C17 H12 Cl2 F3 N7 O2 S" _chem_comp.mon_nstd_parent_comp_id ? _chem_comp.pdbx_synonyms tovorafenib _chem_comp.pdbx_formal_charge 0 _chem_comp.pdbx_initial_date 2019-12-03 _chem_comp.pdbx_modified_date 2023-04-04 _chem_comp.pdbx_ambiguous_flag N _chem_comp.pdbx_release_status REL _chem_comp.pdbx_replaced_by ? _chem_comp.pdbx_replaces ? _chem_comp.formula_weight 506.289 _chem_comp.one_letter_code ? _chem_comp.three_letter_code QOP _chem_comp.pdbx_model_coordinates_details ? _chem_comp.pdbx_model_coordinates_missing_flag N _chem_comp.pdbx_ideal_coordinates_details Corina _chem_comp.pdbx_ideal_coordinates_missing_flag N _chem_comp.pdbx_model_coordinates_db_code 6V34 _chem_comp.pdbx_subcomponent_list ? _chem_comp.pdbx_processing_site RCSB # loop_ _chem_comp_atom.comp_id _chem_comp_atom.atom_id _chem_comp_atom.alt_atom_id _chem_comp_atom.type_symbol _chem_comp_atom.charge _chem_comp_atom.pdbx_align _chem_comp_atom.pdbx_aromatic_flag _chem_comp_atom.pdbx_leaving_atom_flag _chem_comp_atom.pdbx_stereo_config _chem_comp_atom.pdbx_backbone_atom_flag _chem_comp_atom.pdbx_n_terminal_atom_flag _chem_comp_atom.pdbx_c_terminal_atom_flag _chem_comp_atom.model_Cartn_x _chem_comp_atom.model_Cartn_y _chem_comp_atom.model_Cartn_z _chem_comp_atom.pdbx_model_Cartn_x_ideal _chem_comp_atom.pdbx_model_Cartn_y_ideal _chem_comp_atom.pdbx_model_Cartn_z_ideal _chem_comp_atom.pdbx_component_atom_id _chem_comp_atom.pdbx_component_comp_id _chem_comp_atom.pdbx_ordinal QOP C10 C1 C 0 1 Y N N N N N 9.333 -8.121 15.759 -1.832 -1.133 0.778 C10 QOP 1 QOP C13 C2 C 0 1 Y N N N N N 7.086 -7.173 15.513 0.571 -0.926 0.282 C13 QOP 2 QOP C14 C3 C 0 1 N N N N N N 5.598 -6.913 15.282 1.975 -1.027 -0.128 C14 QOP 3 QOP C16 C4 C 0 1 Y N N N N N 3.724 -5.191 15.057 4.194 -0.182 -0.115 C16 QOP 4 QOP C18 C5 C 0 1 Y N N N N N 2.160 -3.878 13.963 5.882 -1.415 -1.092 C18 QOP 5 QOP C21 C6 C 0 1 Y N N N N N 1.408 -5.490 15.555 6.437 0.638 0.000 C21 QOP 6 QOP C22 C7 C 0 1 N N N N N N 0.294 -6.188 16.324 7.446 1.671 0.432 C22 QOP 7 QOP C26 C8 C 0 1 Y N N N N N 2.731 -5.839 15.770 5.095 0.792 0.300 C26 QOP 8 QOP C02 C9 C 0 1 Y N N N N N 10.338 -15.215 16.543 -8.283 1.743 -0.713 C02 QOP 9 QOP C04 C10 C 0 1 Y N N N N N 9.161 -14.002 18.086 -6.445 3.022 -0.180 C04 QOP 10 QOP C06 C11 C 0 1 Y N N N N N 10.074 -12.853 16.310 -6.221 0.733 -0.032 C06 QOP 11 QOP C07 C12 C 0 1 N N N N N N 10.312 -11.513 15.611 -5.388 -0.457 0.269 C07 QOP 12 QOP C09 C13 C 0 1 N N R N N N 10.573 -9.010 15.812 -3.287 -1.478 0.963 C09 QOP 13 QOP C12 C14 C 0 1 Y N N N N N 8.014 -6.173 15.899 0.010 0.100 0.971 C12 QOP 14 QOP C19 C15 C 0 1 Y N N N N N 1.121 -4.494 14.641 6.833 -0.489 -0.707 C19 QOP 15 QOP C29 C16 C 0 1 N N N N N N 11.612 -8.319 16.684 -3.528 -1.916 2.409 C29 QOP 16 QOP C31 C17 C 0 1 Y N N N N N 10.595 -14.052 15.827 -7.543 0.586 -0.442 C31 QOP 17 QOP F23 F1 F 0 1 N N N N N N -0.196 -5.318 17.253 8.395 1.075 1.270 F23 QOP 18 QOP F24 F2 F 0 1 N N N N N N -0.699 -6.563 15.465 8.085 2.198 -0.696 F24 QOP 19 QOP F25 F3 F 0 1 N N N N N N 0.805 -7.291 16.947 6.795 2.700 1.122 F25 QOP 20 QOP N01 N1 N 0 1 N N N N N N 10.845 -16.493 16.078 -9.605 1.653 -1.118 N01 QOP 21 QOP N03 N2 N 0 1 Y N N N N N 9.628 -15.156 17.654 -7.701 2.927 -0.570 N03 QOP 22 QOP N05 N3 N 0 1 Y N N N N N 9.386 -12.876 17.436 -5.714 1.961 0.085 N05 QOP 23 QOP N08 N4 N 0 1 N N N N N N 10.323 -10.304 16.417 -4.109 -0.302 0.665 N08 QOP 24 QOP N11 N5 N 0 1 Y N N N N N 9.353 -6.759 16.036 -1.268 -0.052 1.214 N11 QOP 25 QOP N15 N6 N 0 1 N N N N N N 5.121 -5.537 15.267 2.839 -0.039 0.180 N15 QOP 26 QOP N17 N7 N 0 1 Y N N N N N 3.406 -4.244 14.195 4.609 -1.241 -0.792 N17 QOP 27 QOP O27 O1 O 0 1 N N N N N N 4.862 -7.826 15.112 2.360 -2.002 -0.746 O27 QOP 28 QOP O30 O2 O 0 1 N N N N N N 10.475 -11.443 14.441 -5.859 -1.572 0.159 O30 QOP 29 QOP S28 S1 S 0 1 Y N N N N N 7.825 -8.588 15.370 -0.691 -2.116 -0.029 S28 QOP 30 QOP CL20 CL1 CL 0 0 N N N N N N -0.573 -4.019 14.346 8.505 -0.730 -1.110 CL20 QOP 31 QOP CL32 CL2 CL 0 0 N N N N N N 11.557 -14.132 14.323 -8.254 -0.989 -0.611 CL32 QOP 32 QOP H1 H1 H 0 1 N N N N N N 1.950 -3.099 13.245 6.184 -2.291 -1.646 H1 QOP 33 QOP H2 H2 H 0 1 N N N N N N 2.984 -6.607 16.485 4.752 1.657 0.848 H2 QOP 34 QOP H3 H3 H 0 1 N N N N N N 8.579 -13.977 18.996 -6.002 4.002 -0.074 H3 QOP 35 QOP H4 H4 H 0 1 N N N N N N 10.975 -9.134 14.796 -3.556 -2.290 0.288 H4 QOP 36 QOP H5 H5 H 0 1 N N N N N N 7.772 -5.134 16.067 0.569 0.967 1.291 H5 QOP 37 QOP H6 H6 H 0 1 N N N N N N 12.518 -8.941 16.739 -3.259 -1.103 3.084 H6 QOP 38 QOP H7 H7 H 0 1 N N N N N N 11.864 -7.341 16.248 -4.581 -2.165 2.543 H7 QOP 39 QOP H8 H8 H 0 1 N N N N N N 11.205 -8.175 17.696 -2.916 -2.790 2.631 H8 QOP 40 QOP H9 H9 H 0 1 N N N N N N 10.566 -17.214 16.713 -10.113 2.460 -1.300 H9 QOP 41 QOP H10 H10 H 0 1 N N N N N N 10.475 -16.687 15.169 -10.023 0.784 -1.220 H10 QOP 42 QOP H11 H11 H 0 1 N N N N N N 10.156 -10.365 17.401 -3.733 0.587 0.753 H11 QOP 43 QOP H12 H12 H 0 1 N N N N N N 5.782 -4.799 15.407 2.518 0.770 0.607 H12 QOP 44 # loop_ _chem_comp_bond.comp_id _chem_comp_bond.atom_id_1 _chem_comp_bond.atom_id_2 _chem_comp_bond.value_order _chem_comp_bond.pdbx_aromatic_flag _chem_comp_bond.pdbx_stereo_config _chem_comp_bond.pdbx_ordinal QOP C18 N17 DOUB Y N 1 QOP C18 C19 SING Y N 2 QOP N17 C16 SING Y N 3 QOP CL32 C31 SING N N 4 QOP CL20 C19 SING N N 5 QOP O30 C07 DOUB N N 6 QOP C19 C21 DOUB Y N 7 QOP C16 N15 SING N N 8 QOP C16 C26 DOUB Y N 9 QOP O27 C14 DOUB N N 10 QOP N15 C14 SING N N 11 QOP C14 C13 SING N N 12 QOP S28 C13 SING Y N 13 QOP S28 C10 SING Y N 14 QOP F24 C22 SING N N 15 QOP C13 C12 DOUB Y N 16 QOP C21 C26 SING Y N 17 QOP C21 C22 SING N N 18 QOP C07 C06 SING N N 19 QOP C07 N08 SING N N 20 QOP C10 C09 SING N N 21 QOP C10 N11 DOUB Y N 22 QOP C09 N08 SING N N 23 QOP C09 C29 SING N N 24 QOP C31 C06 DOUB Y N 25 QOP C31 C02 SING Y N 26 QOP C12 N11 SING Y N 27 QOP N01 C02 SING N N 28 QOP C06 N05 SING Y N 29 QOP C22 F25 SING N N 30 QOP C22 F23 SING N N 31 QOP C02 N03 DOUB Y N 32 QOP N05 C04 DOUB Y N 33 QOP N03 C04 SING Y N 34 QOP C18 H1 SING N N 35 QOP C26 H2 SING N N 36 QOP C04 H3 SING N N 37 QOP C09 H4 SING N N 38 QOP C12 H5 SING N N 39 QOP C29 H6 SING N N 40 QOP C29 H7 SING N N 41 QOP C29 H8 SING N N 42 QOP N01 H9 SING N N 43 QOP N01 H10 SING N N 44 QOP N08 H11 SING N N 45 QOP N15 H12 SING N N 46 # loop_ _pdbx_chem_comp_descriptor.comp_id _pdbx_chem_comp_descriptor.type _pdbx_chem_comp_descriptor.program _pdbx_chem_comp_descriptor.program_version _pdbx_chem_comp_descriptor.descriptor QOP SMILES ACDLabs 12.01 c3(C(NC(c1ncnc(c1Cl)N)=O)C)ncc(C(Nc2cc(C(F)(F)F)c(cn2)Cl)=O)s3 QOP InChI InChI 1.03 InChI=1S/C17H12Cl2F3N7O2S/c1-6(28-15(31)12-11(19)13(23)27-5-26-12)16-25-4-9(32-16)14(30)29-10-2-7(17(20,21)22)8(18)3-24-10/h2-6H,1H3,(H,28,31)(H2,23,26,27)(H,24,29,30)/t6-/m1/s1 QOP InChIKey InChI 1.03 VWMJHAFYPMOMGF-ZCFIWIBFSA-N QOP SMILES_CANONICAL CACTVS 3.385 C[C@@H](NC(=O)c1ncnc(N)c1Cl)c2sc(cn2)C(=O)Nc3cc(c(Cl)cn3)C(F)(F)F QOP SMILES CACTVS 3.385 C[CH](NC(=O)c1ncnc(N)c1Cl)c2sc(cn2)C(=O)Nc3cc(c(Cl)cn3)C(F)(F)F QOP SMILES_CANONICAL "OpenEye OEToolkits" 2.0.7 C[C@H](c1ncc(s1)C(=O)Nc2cc(c(cn2)Cl)C(F)(F)F)NC(=O)c3c(c(ncn3)N)Cl QOP SMILES "OpenEye OEToolkits" 2.0.7 CC(c1ncc(s1)C(=O)Nc2cc(c(cn2)Cl)C(F)(F)F)NC(=O)c3c(c(ncn3)N)Cl # loop_ _pdbx_chem_comp_identifier.comp_id _pdbx_chem_comp_identifier.type _pdbx_chem_comp_identifier.program _pdbx_chem_comp_identifier.program_version _pdbx_chem_comp_identifier.identifier QOP "SYSTEMATIC NAME" ACDLabs 12.01 6-amino-5-chloro-N-[(1R)-1-(5-{[5-chloro-4-(trifluoromethyl)pyridin-2-yl]carbamoyl}-1,3-thiazol-2-yl)ethyl]pyrimidine-4-carboxamide QOP "SYSTEMATIC NAME" "OpenEye OEToolkits" 2.0.7 2-[(1~{R})-1-[(6-azanyl-5-chloranyl-pyrimidin-4-yl)carbonylamino]ethyl]-~{N}-[5-chloranyl-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide # loop_ _pdbx_chem_comp_audit.comp_id _pdbx_chem_comp_audit.action_type _pdbx_chem_comp_audit.date _pdbx_chem_comp_audit.processing_site QOP 'Create component' 2019-12-03 RCSB QOP 'Initial release' 2020-12-02 RCSB QOP 'Modify synonyms' 2023-04-04 RCSB # _pdbx_chem_comp_synonyms.ordinal 1 _pdbx_chem_comp_synonyms.comp_id QOP _pdbx_chem_comp_synonyms.name tovorafenib _pdbx_chem_comp_synonyms.provenance AUTHOR _pdbx_chem_comp_synonyms.type "international nonproprietary name" # _pdbe_chem_comp_drugbank_details.comp_id QOP _pdbe_chem_comp_drugbank_details.drugbank_id DB15266 _pdbe_chem_comp_drugbank_details.type 'small molecule' _pdbe_chem_comp_drugbank_details.name Tovorafenib _pdbe_chem_comp_drugbank_details.description 'Tovorafenib is a selective type II RAF kinase inhibitor with anti-tumour activity.[A263597] It was granted accelerated approval by the FDA, making it the first FDA approval of a systemic therapy for the treatment of pediatric low-grade glioma, with BRAF rearrangements.[L50587] BRAF oncogenic mutations in cancers drive dysregulated cell growth, proliferation, and differentiation.[A263602] Tovorafenib inhibits BRAF and blocks dysregulated signalling pathways related to cancer cell growth and survival.[L50587]' _pdbe_chem_comp_drugbank_details.cas_number 1096708-71-2 _pdbe_chem_comp_drugbank_details.mechanism_of_action 'Pediatric low-grade glioma, the most common childhood central nervous system (CNS) tumour, is often associated with BRAF genomic alterations, such as BRAF fusion or rearrangement.[A263597, A263602] The BRAF kinase family is activated by RAS to phosphorylate MEK1/2, which phosphorylates ERK1/2 and promotes downstream signalling cascades that regulate multiple cellular processes, such as cell growth, proliferation, and differentiation.[A263602] Oncogenic mutations in BRAF lead to an aberrant and hyperactivated RAS-RAF-MEK-ERK pathway, also known as the mitogen-activated protein kinase (MAPK) signalling pathway.[A263607] Several RAF kinase inhibitors have been developed to treat cancers with BRAF mutations. These RAF inhibitors have been categorized into different "types" depending on their selectivity to a BRAF isoform and binding modes.[A263602] Tovorafenib is a Type II RAF kinase inhibitor. RAF has a conserved three-residue segment (Asp-Phe-Gly) located at the N-terminus of the kinase activation loop called a DFG motif. In a state called a “DGF-out” conformation, the DFG motif is flipped in a way that reorients the phenylalanine residue, leaving a vacant site in which the drug can extend from the ATP site to insert a hydrophobic group.[A263602] Tovorafenib is active against mutant BRAF V600E, wild-type BRAF, and wild-type CRAF kinases.[A263607, L50582] Tovorafenib exhibited antitumor activity in cultured cells and xenograft tumour models harbouring BRAF V600E and V600D mutations, and in a xenograft model harbouring a BRAF fusion.[L50582] Tovorafenib is not reported to induce paradoxical activation of the MAPK pathway.[A263597]' # loop_ _pdbe_chem_comp_synonyms.comp_id _pdbe_chem_comp_synonyms.name _pdbe_chem_comp_synonyms.provenance _pdbe_chem_comp_synonyms.type QOP tovorafenib wwPDB ? QOP '4-Pyrimidinecarboxamide, 6-amino-5-chloro-N-[(1R)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-' DrugBank ? QOP 6-Amino-5-chloro-N-((1R)-1-(5-(((5-chloro-4-(trifluoromethyl)-2-pyridinyl)amino)carbonyl)-2-thiazolyl)ethyl)-4-pyrimidinecarboxamide DrugBank ? QOP '6-amino-5-chloro-N-[1R)-1-[5-[[[5-hloro-4-(trifluoromethyl)-2pyridinyl]amino]carbonyl]-2-thiazoyl]ethyl]-4-pyrimdinecarboxamide' DrugBank ? # loop_ _pdbe_chem_comp_drugbank_targets.comp_id _pdbe_chem_comp_drugbank_targets.drugbank_id _pdbe_chem_comp_drugbank_targets.name _pdbe_chem_comp_drugbank_targets.organism _pdbe_chem_comp_drugbank_targets.uniprot_id _pdbe_chem_comp_drugbank_targets.pharmacologically_active _pdbe_chem_comp_drugbank_targets.ordinal QOP DB15266 'RAF proto-oncogene serine/threonine-protein kinase' Humans P04049 yes 1 QOP DB15266 'Serine/threonine-protein kinase A-Raf' Humans P10398 unknown 2 QOP DB15266 'Serine/threonine-protein kinase B-raf' Humans P15056 unknown 3 # loop_ _software.name _software.version _software.description rdkit 2025.03.3 'Core functionality.' pdbeccdutils 1.0.0 'Wrapper to provide 2D templates and molecular fragments.' # loop_ _pdbe_chem_comp_atom_depiction.comp_id _pdbe_chem_comp_atom_depiction.atom_id _pdbe_chem_comp_atom_depiction.element _pdbe_chem_comp_atom_depiction.model_Cartn_x _pdbe_chem_comp_atom_depiction.model_Cartn_y _pdbe_chem_comp_atom_depiction.pdbx_ordinal QOP C10 C 11.869 -0.967 1 QOP C13 C 9.495 -0.463 2 QOP C14 C 8.196 0.287 3 QOP C16 C 6.897 2.537 4 QOP C18 C 4.299 2.537 5 QOP C21 C 5.598 4.787 6 QOP C22 C 5.598 6.287 7 QOP C26 C 6.897 4.037 8 QOP C02 C 16.888 -5.665 9 QOP C04 C 18.990 -4.138 10 QOP C06 C 16.616 -3.081 11 QOP C07 C 15.734 -1.867 12 QOP C09 C 13.361 -0.810 13 QOP C12 C 9.652 -1.954 14 QOP C19 C 4.299 4.037 15 QOP C29 C 13.971 0.560 16 QOP C31 C 16.006 -4.451 17 QOP F23 F 4.098 6.287 18 QOP F24 F 5.598 7.787 19 QOP F25 F 7.098 6.287 20 QOP N01 N 16.277 -7.035 21 QOP N03 N 18.380 -5.508 22 QOP N05 N 18.108 -2.924 23 QOP N08 N 14.243 -2.024 24 QOP N11 N 11.119 -2.266 25 QOP N15 N 8.196 1.787 26 QOP N17 N 5.598 1.787 27 QOP O27 O 6.897 -0.463 28 QOP O30 O 16.345 -0.497 29 QOP S28 S 10.866 0.147 30 QOP CL20 Cl 3.000 4.787 31 QOP CL32 Cl 14.514 -4.608 32 # loop_ _pdbe_chem_comp_bond_depiction.comp_id _pdbe_chem_comp_bond_depiction.atom_id_1 _pdbe_chem_comp_bond_depiction.atom_id_2 _pdbe_chem_comp_bond_depiction.value_order _pdbe_chem_comp_bond_depiction.bond_dir _pdbe_chem_comp_bond_depiction.pdbx_ordinal QOP C18 N17 DOUBLE NONE 1 QOP C18 C19 SINGLE NONE 2 QOP N17 C16 SINGLE NONE 3 QOP CL32 C31 SINGLE NONE 4 QOP CL20 C19 SINGLE NONE 5 QOP O30 C07 DOUBLE NONE 6 QOP C19 C21 DOUBLE NONE 7 QOP C16 N15 SINGLE NONE 8 QOP C16 C26 DOUBLE NONE 9 QOP O27 C14 DOUBLE NONE 10 QOP N15 C14 SINGLE NONE 11 QOP C14 C13 SINGLE NONE 12 QOP S28 C13 SINGLE NONE 13 QOP S28 C10 SINGLE NONE 14 QOP F24 C22 SINGLE NONE 15 QOP C13 C12 DOUBLE NONE 16 QOP C21 C26 SINGLE NONE 17 QOP C21 C22 SINGLE NONE 18 QOP C07 C06 SINGLE NONE 19 QOP C07 N08 SINGLE NONE 20 QOP C10 C09 SINGLE NONE 21 QOP C10 N11 DOUBLE NONE 22 QOP C09 N08 SINGLE NONE 23 QOP C09 C29 SINGLE BEGINWEDGE 24 QOP C31 C06 SINGLE NONE 25 QOP C31 C02 DOUBLE NONE 26 QOP C12 N11 SINGLE NONE 27 QOP N01 C02 SINGLE NONE 28 QOP C06 N05 DOUBLE NONE 29 QOP C22 F25 SINGLE NONE 30 QOP C22 F23 SINGLE NONE 31 QOP C02 N03 SINGLE NONE 32 QOP N05 C04 SINGLE NONE 33 QOP N03 C04 DOUBLE NONE 34 # loop_ _pdbe_chem_comp_substructure.comp_id _pdbe_chem_comp_substructure.substructure_name _pdbe_chem_comp_substructure.id _pdbe_chem_comp_substructure.substructure_type _pdbe_chem_comp_substructure.substructure_smiles _pdbe_chem_comp_substructure.substructure_inchis _pdbe_chem_comp_substructure.substructure_inchikeys QOP MurckoScaffold S1 scaffold O=C(NCc1ncc(C(=O)Nc2ccccn2)s1)c1ccncn1 InChI=1S/C15H12N6O2S/c22-14(10-4-6-16-9-20-10)19-8-13-18-7-11(24-13)15(23)21-12-3-1-2-5-17-12/h1-7,9H,8H2,(H,19,22)(H,17,21,23) PGTVRQDCFPRBNF-UHFFFAOYSA-N QOP amide F1 fragment CC(N)=O InChI=1S/C2H5NO/c1-2(3)4/h1H3,(H2,3,4) DLFVBJFMPXGRIB-UHFFFAOYSA-N QOP pyridine F2 fragment c1ccncc1 InChI=1S/C5H5N/c1-2-4-6-5-3-1/h1-5H JUJWROOIHBZHMG-UHFFFAOYSA-N QOP pyrimidine F3 fragment c1cncnc1 InChI=1S/C4H4N2/c1-2-5-4-6-3-1/h1-4H CZPWVGJYEJSRLH-UHFFFAOYSA-N QOP thiazole F4 fragment c1cscn1 InChI=1S/C3H3NS/c1-2-5-3-4-1/h1-3H FZWLAAWBMGSTSO-UHFFFAOYSA-N QOP Z969560582 F5 fragment CNC(=O)c1cnc(C)s1 InChI=1S/C6H8N2OS/c1-4-8-3-5(10-4)6(9)7-2/h3H,1-2H3,(H,7,9) PUIJVJNJITYIIM-UHFFFAOYSA-N QOP Z1267773633 F6 fragment CCc1ncc(CNC)s1 InChI=1S/C7H12N2S/c1-3-7-9-5-6(10-7)4-8-2/h5,8H,3-4H2,1-2H3 CSZFIJNBBMUGDN-UHFFFAOYSA-N # loop_ _pdbe_chem_comp_substructure_mapping.comp_id _pdbe_chem_comp_substructure_mapping.atom_id _pdbe_chem_comp_substructure_mapping.substructure_id _pdbe_chem_comp_substructure_mapping.substructure_ordinal QOP C10 S1 1 QOP C13 S1 1 QOP C14 S1 1 QOP C16 S1 1 QOP C18 S1 1 QOP C21 S1 1 QOP C26 S1 1 QOP C02 S1 1 QOP C04 S1 1 QOP C06 S1 1 QOP C07 S1 1 QOP C09 S1 1 QOP C12 S1 1 QOP C19 S1 1 QOP C31 S1 1 QOP N03 S1 1 QOP N05 S1 1 QOP N08 S1 1 QOP N11 S1 1 QOP N15 S1 1 QOP N17 S1 1 QOP O27 S1 1 QOP O30 S1 1 QOP S28 S1 1 QOP N08 F1 1 QOP C07 F1 1 QOP O30 F1 1 QOP C06 F1 1 QOP N15 F1 2 QOP C14 F1 2 QOP O27 F1 2 QOP C13 F1 2 QOP C16 F2 1 QOP C26 F2 1 QOP C21 F2 1 QOP C19 F2 1 QOP C18 F2 1 QOP N17 F2 1 QOP C31 F3 1 QOP C06 F3 1 QOP N05 F3 1 QOP C04 F3 1 QOP N03 F3 1 QOP C02 F3 1 QOP C13 F4 1 QOP C12 F4 1 QOP N11 F4 1 QOP C10 F4 1 QOP S28 F4 1 QOP C16 F5 1 QOP N15 F5 1 QOP C14 F5 1 QOP O27 F5 1 QOP C13 F5 1 QOP C12 F5 1 QOP N11 F5 1 QOP C10 F5 1 QOP C09 F5 1 QOP S28 F5 1 QOP C29 F6 1 QOP C09 F6 1 QOP C10 F6 1 QOP N11 F6 1 QOP C12 F6 1 QOP C13 F6 1 QOP C14 F6 1 QOP N15 F6 1 QOP C16 F6 1 QOP S28 F6 1 # _pdbe_chem_comp_rdkit_properties.comp_id QOP _pdbe_chem_comp_rdkit_properties.exactmw 505.010 _pdbe_chem_comp_rdkit_properties.amw 506.297 _pdbe_chem_comp_rdkit_properties.lipinskiHBA 9 _pdbe_chem_comp_rdkit_properties.lipinskiHBD 4 _pdbe_chem_comp_rdkit_properties.NumRotatableBonds 7 _pdbe_chem_comp_rdkit_properties.NumHBD 3 _pdbe_chem_comp_rdkit_properties.NumHBA 8 _pdbe_chem_comp_rdkit_properties.NumHeavyAtoms 32 _pdbe_chem_comp_rdkit_properties.NumAtoms 44 _pdbe_chem_comp_rdkit_properties.NumHeteroatoms 15 _pdbe_chem_comp_rdkit_properties.NumAmideBonds 2 _pdbe_chem_comp_rdkit_properties.FractionCSP3 0.176 _pdbe_chem_comp_rdkit_properties.NumRings 3 _pdbe_chem_comp_rdkit_properties.NumAromaticRings 3 _pdbe_chem_comp_rdkit_properties.NumAliphaticRings 0 _pdbe_chem_comp_rdkit_properties.NumSaturatedRings 0 _pdbe_chem_comp_rdkit_properties.NumHeterocycles 3 _pdbe_chem_comp_rdkit_properties.NumAromaticHeterocycles 3 _pdbe_chem_comp_rdkit_properties.NumSaturatedHeterocycles 0 _pdbe_chem_comp_rdkit_properties.NumAliphaticHeterocycles 0 _pdbe_chem_comp_rdkit_properties.NumSpiroAtoms 0 _pdbe_chem_comp_rdkit_properties.NumBridgeheadAtoms 0 _pdbe_chem_comp_rdkit_properties.NumAtomStereoCenters 1 _pdbe_chem_comp_rdkit_properties.NumUnspecifiedAtomStereoCenters 0 _pdbe_chem_comp_rdkit_properties.labuteASA 208.847 _pdbe_chem_comp_rdkit_properties.tpsa 135.780 _pdbe_chem_comp_rdkit_properties.CrippenClogP 2.999 _pdbe_chem_comp_rdkit_properties.CrippenMR 108.940 _pdbe_chem_comp_rdkit_properties.chi0v 17.073 _pdbe_chem_comp_rdkit_properties.chi1v 9.241 _pdbe_chem_comp_rdkit_properties.chi2v 4.769 _pdbe_chem_comp_rdkit_properties.chi3v 4.769 _pdbe_chem_comp_rdkit_properties.chi4v 2.868 _pdbe_chem_comp_rdkit_properties.chi0n 26.745 _pdbe_chem_comp_rdkit_properties.chi1n 13.457 _pdbe_chem_comp_rdkit_properties.chi2n 3.200 _pdbe_chem_comp_rdkit_properties.chi3n 3.200 _pdbe_chem_comp_rdkit_properties.chi4n 1.855 _pdbe_chem_comp_rdkit_properties.hallKierAlpha -3.030 _pdbe_chem_comp_rdkit_properties.kappa1 12.274 _pdbe_chem_comp_rdkit_properties.kappa2 9.222 _pdbe_chem_comp_rdkit_properties.kappa3 5.231 _pdbe_chem_comp_rdkit_properties.Phi 3.537 # loop_ _pdbe_chem_comp_external_mappings.comp_id _pdbe_chem_comp_external_mappings.source _pdbe_chem_comp_external_mappings.resource _pdbe_chem_comp_external_mappings.resource_id QOP UniChem DrugBank DB15266 QOP UniChem 'Guide to Pharmacology' 9977 QOP UniChem ChEBI 167672 QOP UniChem ZINC ZINC000043202464 QOP UniChem fdasrs ZN90E4027M QOP UniChem PharmGKB PA166345561 QOP UniChem Selleck mln2480 QOP UniChem LINCS LSM-45644 QOP UniChem BindingDb 209864 QOP UniChem 'EPA CompTox Dashboard' DTXSID70149011 QOP UniChem ClinicalTrials BIIB-024 QOP UniChem ClinicalTrials BIIB024 QOP UniChem ClinicalTrials DAY-101 QOP UniChem ClinicalTrials DAY101 QOP UniChem ClinicalTrials MLN-2480 QOP UniChem ClinicalTrials 'TAK 580' QOP UniChem ClinicalTrials TAK-580 QOP UniChem ClinicalTrials TOVORAFENIB QOP UniChem MedChemExpress HY-15246 QOP UniChem 'Probes And Drugs' PD003661 QOP UniChem ChemicalBook CB32604199 QOP UniChem SureChEMBL SCHEMBL4206123 QOP UniChem 'PubChem TPHARMA' 57255246 QOP UniChem PubChem 25161177 # loop_ _pdbe_chem_comp_rdkit_conformer.comp_id _pdbe_chem_comp_rdkit_conformer.atom_id _pdbe_chem_comp_rdkit_conformer.Cartn_x_rdkit _pdbe_chem_comp_rdkit_conformer.Cartn_y_rdkit _pdbe_chem_comp_rdkit_conformer.Cartn_z_rdkit _pdbe_chem_comp_rdkit_conformer.rdkit_method _pdbe_chem_comp_rdkit_conformer.rdkit_ordinal QOP C10 -1.134 -1.512 1.556 ETKDGv3 1 QOP C13 0.971 -0.698 0.445 ETKDGv3 2 QOP C14 2.106 0.027 -0.153 ETKDGv3 3 QOP C16 4.445 -0.105 -1.134 ETKDGv3 4 QOP C18 6.325 -0.108 -2.618 ETKDGv3 5 QOP C21 6.377 1.331 -0.645 ETKDGv3 6 QOP C22 7.027 2.350 0.266 ETKDGv3 7 QOP C26 5.033 0.785 -0.314 ETKDGv3 8 QOP C02 -5.973 1.414 -1.231 ETKDGv3 9 QOP C04 -6.940 -0.674 -1.865 ETKDGv3 10 QOP C06 -4.977 -0.691 -0.508 ETKDGv3 11 QOP C07 -3.957 -1.459 0.231 ETKDGv3 12 QOP C09 -2.445 -1.740 2.250 ETKDGv3 13 QOP C12 0.871 -2.022 0.597 ETKDGv3 14 QOP C19 6.995 0.893 -1.764 ETKDGv3 15 QOP C29 -2.360 -1.258 3.700 ETKDGv3 16 QOP C31 -4.977 0.800 -0.557 ETKDGv3 17 QOP F23 6.211 2.661 1.340 ETKDGv3 18 QOP F24 8.217 1.845 0.757 ETKDGv3 19 QOP F25 7.279 3.513 -0.437 ETKDGv3 20 QOP N01 -6.050 2.840 -1.334 ETKDGv3 21 QOP N03 -6.975 0.623 -1.892 ETKDGv3 22 QOP N05 -5.900 -1.350 -1.147 ETKDGv3 23 QOP N08 -3.520 -1.045 1.535 ETKDGv3 24 QOP N11 -0.333 -2.478 1.234 ETKDGv3 25 QOP N15 3.161 -0.675 -0.832 ETKDGv3 26 QOP N17 5.146 -0.556 -2.304 ETKDGv3 27 QOP O27 2.120 1.286 -0.096 ETKDGv3 28 QOP O30 -3.512 -2.527 -0.271 ETKDGv3 29 QOP S28 -0.478 0.087 1.122 ETKDGv3 30 QOP CL20 8.589 1.460 -2.255 ETKDGv3 31 QOP CL32 -3.644 1.726 0.138 ETKDGv3 32 QOP H1 6.815 -0.474 -3.510 ETKDGv3 33 QOP H2 4.543 1.083 0.603 ETKDGv3 34 QOP H3 -7.704 -1.246 -2.375 ETKDGv3 35 QOP H4 -2.671 -2.830 2.268 ETKDGv3 36 QOP H5 1.639 -2.718 0.289 ETKDGv3 37 QOP H6 -1.552 -1.800 4.237 ETKDGv3 38 QOP H7 -3.321 -1.458 4.221 ETKDGv3 39 QOP H8 -2.153 -0.167 3.740 ETKDGv3 40 QOP H9 -5.374 3.478 -0.861 ETKDGv3 41 QOP H10 -6.823 3.274 -1.886 ETKDGv3 42 QOP H11 -4.043 -0.278 2.016 ETKDGv3 43 QOP H12 2.947 -1.607 -1.252 ETKDGv3 44 #